AIIC AI Intelligence Centre

SOURCE-LINKED INTELLIGENCE

Intelligent Personalised Disease Monitoring Device: a-Doc

CORDIS · observation · Publication date unknown

diseases have unpredictable flares in disease activity despite stable medication, and the causes of such flares differ between patients and are largely unidentifiable. Our deep-tech innovation is an Artificial Intelligence approach to the Monitoring of Autoimmune Diseases at Home with a Novel Biomarker Algorithm: Through 15 years of research in this field, the founder of Kaass Discovery, Dr Anita Kaass, has shown a key biomarker, Gonadotropin releasing hormone (GnRH), is common to several autoimmune diseases. It has been scientifically shown that GnRH levels increase with increasing disease activity. Kaass Discovery is developing a highly novel, deep tech solution to allow autoimmune disease patients to self-manage their conditions and minimize or even eliminate the symptoms of autoimmune diseases. The solution, which we call ‘a-Doc’, uses a saliva sample to indicate disease activity and provide an accurate, instantaneous value. In line with this need, it is also low cost, accurate and simple to use ensuring it is suitable for home use. The data collected from the device will be

Read original source ↗ Open in workspace

recordType
award
status
CLOSED
region
EU
value
75000
unit
EUR

Evidence & attribution

European Commission, CORDIS Horizon Europe project dataset. Metadata adapted.

License: CORDIS reuse policy

First collected: 2026-09-20T00:21:03.701Z. This is not the publication date.